BE709012A - - Google Patents

Info

Publication number
BE709012A
BE709012A BE709012DA BE709012A BE 709012 A BE709012 A BE 709012A BE 709012D A BE709012D A BE 709012DA BE 709012 A BE709012 A BE 709012A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE709012A publication Critical patent/BE709012A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE709012D 1967-01-10 1968-01-05 BE709012A (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR90478A FR6087M (en:Method) 1967-01-10 1967-01-10
FR133258A FR6934M (en:Method) 1967-01-10 1967-12-21

Publications (1)

Publication Number Publication Date
BE709012A true BE709012A (en:Method) 1968-05-16

Family

ID=26174501

Family Applications (1)

Application Number Title Priority Date Filing Date
BE709012D BE709012A (en:Method) 1967-01-10 1968-01-05

Country Status (13)

Country Link
US (1) US3542870A (en:Method)
AT (1) AT278750B (en:Method)
BE (1) BE709012A (en:Method)
CH (1) CH485658A (en:Method)
DE (1) DE1668930C3 (en:Method)
DK (1) DK120400B (en:Method)
ES (1) ES349044A1 (en:Method)
FI (1) FI48067C (en:Method)
FR (2) FR6087M (en:Method)
GB (1) GB1146139A (en:Method)
SE (1) SE349020B (en:Method)
SU (1) SU456406A3 (en:Method)
YU (1) YU34272B (en:Method)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE7689T1 (de) 1980-07-09 1984-06-15 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
JPS6058927A (ja) * 1983-09-09 1985-04-05 Nippon Mejifuijitsukusu Kk 放射能標識血小板製剤
US4699928A (en) * 1984-07-13 1987-10-13 Merrell Dow Pharmaceuticals Inc. Fluoroallylamine derivatives
US6650943B1 (en) 2000-04-07 2003-11-18 Advanced Bionics Corporation Fully implantable neurostimulator for cavernous nerve stimulation as a therapy for erectile dysfunction and other sexual dysfunction
US6885895B1 (en) * 2001-04-26 2005-04-26 Advanced Bionics Corporation Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
DE60336485D1 (de) 2002-08-19 2011-05-05 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
WO2005089741A2 (en) * 2004-03-17 2005-09-29 Sosei R&D Ltd. The treatment of inflammatory disorders and pain using beta-aminoalcohols
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN113574055B (zh) 2019-01-18 2024-07-23 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2661372A (en) * 1953-12-01 Pharmacologically valuable stereo
GB789033A (en) * 1954-10-23 1958-01-15 Philips Nv Improvements in or relating to substituted aralkyl-phenyl-alkylamines
GB800718A (en) * 1955-05-28 1958-09-03 Philips Nv Novel substituted alkylamines and processes for their production
FR1165845A (fr) * 1955-05-28 1958-10-29 Philips Nv Amines secondaires portant des substituants et leur préparation
DE1250450B (de) * 1962-03-31 1967-09-21 Deutsche Gold- und Silber-Scheideanstalt vormals Roessler, Frankfurt/M Verfahren zur Herstellung von Aminoalkoholen sowie deren Säureadditionssalzen und quartären Ammoniumverbindungen
NL130079C (en:Method) * 1963-06-28
FR3654M (fr) * 1963-11-08 1965-11-02 Raymond Michel β(-3:5 diiodo-4 hydroxyphényl) βhydroxy αméthyl n méthyléthylamine-synthese et a titre d'hypertenseur a action prolongée, son utilisation dans le traitement des collapsus cardiovasculaires.

Also Published As

Publication number Publication date
ES349044A1 (es) 1969-08-16
YU4668A (en) 1978-10-31
DE1668930B2 (de) 1973-08-02
FR6934M (en:Method) 1969-05-05
GB1146139A (en) 1969-03-19
FR6087M (en:Method) 1968-06-04
SU456406A3 (ru) 1975-01-05
DE1668930A1 (de) 1971-09-16
FI48067C (fi) 1974-06-10
DK120400B (da) 1971-05-24
FI48067B (en:Method) 1974-02-28
SE349020B (en:Method) 1972-09-18
US3542870A (en) 1970-11-24
YU34272B (en) 1979-04-30
DE1668930C3 (de) 1974-02-28
AT278750B (de) 1970-02-10
CH485658A (fr) 1970-02-15

Similar Documents

Publication Publication Date Title
AU425114B2 (en:Method)
AU342066A (en:Method)
AU3189468A (en:Method)
AU2256867A (en:Method)
AU2528767A (en:Method)
AU2977667A (en:Method)
AU3151267A (en:Method)
AU1273466A (en:Method)
AU2116667A (en:Method)
AU610966A (en:Method)
BE162295A (en:Method)
BE692198A (en:Method)
AU25066A (en:Method)
AU23366A (en:Method)
AU1868267A (en:Method)
AU3054676A (en:Method)
AU34866A (en:Method)
AU408412B2 (en:Method)
AU1763766A (en:Method)
AU459699A (en:Method)
AU1677166A (en:Method)
AU1614766A (en:Method)
AU97666A (en:Method)
BE692779A (en:Method)
BE426053A (en:Method)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: LABORATOIRES HOUDE

Effective date: 19880105